[HTML][HTML] Comparative efficacy and safety of treatment regimens for Pneumocystis jirovecii pneumonia in people living with HIV–A systematic review and network meta …

S Hatzl, F Posch, L Scholz, C Geiger, L Kriegl… - Clinical Microbiology …, 2024 - Elsevier
Background Pneumocystis jirovecii pneumonia (PCP) is a serious opportunistic infection in
people living with HIV (PWH) who have low CD4 counts. Despite its side effects …

Mucosal immune response in biology, disease prevention and treatment

X Zhou, Y Wu, Z Zhu, C Lu, C Zhang, L Zeng… - … and Targeted Therapy, 2025 - nature.com
The mucosal immune system, as the most extensive peripheral immune network, serves as
the frontline defense against a myriad of microbial and dietary antigens. It is crucial in …

Optimizing inpatient care for lung cancer patients with immune checkpoint inhibitor-related pneumonitis using a clinical care pathway algorithm

N Brito-Dellan, MC Franco-Vega, JI Ruiz, M Lu… - Supportive Care in …, 2024 - Springer
Purpose Immune checkpoint inhibitor-related pneumonitis (ICI-P) is a condition associated
with high mortality, necessitating prompt recognition and treatment initiation. This study …

Fungal lung disease

TK Jaggi, R Agarwal, PY Tiew, A Shah… - European …, 2024 - publications.ersnet.org
Fungal lung disease encompasses a wide spectrum of organisms and associated clinical
conditions, presenting a significant global health challenge. The type and severity of disease …

Severe Pneumocystis jirovecii pneumonia: time to reassess our practices

S Nseir, E Valadas, M Leone - Intensive Care Medicine, 2024 - Springer
Pneumocystis jirovecii pneumonia (PJP) is an opportunistic fungal pneumonia that affects
immunocompromised patients [1]. Although its incidence is quite low (less than five cases …

Prognostic analysis of Pneumocystis jirovecii pneumonia in patients with systemic vasculitides: a retrospective cohort study

R Chen, Y Shi, H Sun, K Xu, Z Li, M Wang, C Shao… - Clinical …, 2024 - Springer
Objectives Pneumocystis jirovecii pneumonia (PJP) is a serious complication of autoimmune
and inflammatory diseases. This study aimed to describe the characteristics of PJP in …

[HTML][HTML] Fungal Infections in Kidney Transplant Recipients: A Comprehensive Narrative Review

M Mazzitelli, F Nalesso, AE Maraolo, V Scaglione… - Microorganisms, 2025 - mdpi.com
Background: Despite kidney transplantation being a life-saving procedure, patients
experience a high risk of developing fungal infections (FIs), with an increased risk of both …

Pneumocystis pneumonia in intensive care: clinical spectrum, prophylaxis patterns, antibiotic treatment delay impact, and role of corticosteroids. A French multicentre …

T Kamel, R Janssen-Langenstein, Q Quelven… - Intensive Care …, 2024 - Springer
Abstract Purpose Severe Pneumocystis jirovecii pneumonia (PJP) requiring intensive care
has been the subject of few prospective studies. It is unclear whether delayed curative …

Pulmonary Immunocompromise in Human Immunodeficiency Virus Disease

EF Attia, E Maleche-Obimbo… - Clinics in Chest …, 2024 - chestmed.theclinics.com
Pulmonary Immunocompromise in Human Immunodeficiency Virus Disease - Clinics in Chest
Medicine Skip to Main Content Skip to Main Menu Advertisement Clinics in Chest Medicine …

Pulmonary Immunocompromise in Chronic and High-dose Steroid Therapy

M Kang, R Cavallazzi - Clinics in Chest Medicine, 2025 - chestmed.theclinics.com
Glucocorticoid (GC) use is often the mainstay of treatment in many pulmonary, autoimmune,
allergic, and oncologic diseases, along with organ transplantation. Short-term and long-term …